Target intelligence / Profile preview

Host-cell pathways regulating influenza hemagglutinin post-translational maturation

Molecular classification
Enzyme, Chaperone, Protease, Glycosyltransferase, Acyltransferase
01

Overview

Host-cell pathways regulating influenza hemagglutinin (HA) post-translational maturation encompass a series of essential biochemical processes that transform the nascent HA polypeptide into a functional, infectious protein. This maturation occurs within the host's secretory pathway and includes N-linked glycosylation, chaperone-mediated folding (involving calnexin and calreticulin), disulfide bond formation, and trimerization in the endoplasmic reticulum (ER) (Sun & Whittaker, 2013, DOI: 10.1111/j.1600-0854.2012.01456.x). A critical final step is the proteolytic cleavage of the precursor HA0 into HA1 and HA2 subunits by host-cell proteases such as Furin or members of the Type II Transmembrane Serine Protease (TTSP) family, like TMPRSS2 and TMPRSS4, which is a prerequisite for viral membrane fusion and infectivity (Böttcher-Friebertshäuser et al., 2013, DOI: 10.1016/j.virs.2012.11.001). Additionally, palmitoylation of the HA cytoplasmic tail by host ZDHHC enzymes is often required for efficient viral assembly. Targeting these host pathways, rather than the virus itself, represents a host-directed therapeutic strategy aimed at reducing the likelihood of viral resistance. For example, ER glucosidase inhibitors like celgosivir disrupt HA folding, while protease inhibitors like camostat mesylate block the activation of the virus, effectively neutralizing its ability to spread (Warfield et al., 2016, DOI: 10.1371/journal.pone.0150640).

Other names
Influenza HA maturation pathwaysHost-directed influenza targetsHA0 processing machineryInfluenza hemagglutinin post-translational modification
02

Mechanism of action

Inhibition of host-cell proteases (e.g., TMPRSS2, Furin) to prevent HA0 cleavage; inhibition of ER glucosidases to disrupt HA folding and trafficking; inhibition of palmitoyltransferases to prevent HA membrane anchoring.

03

Biological functions

Protein foldingProteolysisGlycosylationLipid modificationViral entryViral assembly
04

Disease associations

Infection
05

Safety considerations

Interference with essential host protein maturationPotential for systemic toxicity due to inhibition of ubiquitous proteasesER stress inductionOff-target effects on host immune signaling proteins
06

Interacting drugs

Camostat mesylate

5 more in the full profile.

07

Biomarkers

Viral titerHA0/HA1/HA2 cleavage ratioSurface expression of hemagglutininPlaque reduction assay

Beyond the preview

Go deeper on Host-cell pathways regulating influenza hemagglutinin post-translational maturation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host-cell pathways regulating influenza hemagglutinin post-translational maturation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call